Skip to main content

Healthcare

Arsenal Capital Partners Adds Dr. Richard Eglen as Senior Advisor to its Healthcare Team

September 23, 2020

NEW YORK, September 23, 2020 -- Arsenal Capital Partners ("Arsenal"), a private equity firm that specializes in investments in healthcare and industrial companies, today announced its partnership with Dr. Richard Eglen as a Senior Advisor to its healthcare team.  Dr.

Read More about Arsenal Capital Partners Adds Dr. Richard Eglen as Senior Advisor to its Healthcare Team

Arsenal Capital Partners Completes £182 Million Acquisition of Cello Health

August 11, 2020

Acquisition reflects ambition to build an enterprise designed to enable healthcare clients to maximize the value of their products and accelerate patient access to medical and technological advances

Read More about Arsenal Capital Partners Completes £182 Million Acquisition of Cello Health

Arsenal Capital Partners Announces Two New Investment Partners; Dr. John Mattison Named Operating Partner & Chief Medical Information Officer

July 13, 2020

NEW YORK, July 13, 2020 - Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in specialty industrials and healthcare companies, today announced several significant human capital updates. 

Read More about Arsenal Capital Partners Announces Two New Investment Partners; Dr. John Mattison Named Operating Partner & Chief Medical Information Officer

Pharma Value Demonstration Makes Recommended Cash Offer to Acquire Cello Health plc

July 1, 2020
Pharma Value Demonstration, a portfolio company of Arsenal, reached an agreement with the board of Cello Health plc on the terms of a recommended cash offer for the entire issued, and to be issued, share capital of Cello. 
Read More about Pharma Value Demonstration Makes Recommended Cash Offer to Acquire Cello Health plc

Arsenal Completes BresMed Acquisition; First Step to the Creation of a New Science- and Technology-Driven Value Demonstration Group

February 26, 2020
Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
Read More about Arsenal Completes BresMed Acquisition; First Step to the Creation of a New Science- and Technology-Driven Value Demonstration Group
Subscribe to Healthcare